Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIEKIRA PAK in Real World Chronic Hepatitis C Genotype 1
NCT02461745Phase 4Completed
- Sponsor
- Kaiser Permanente
- Start
- Jun 2015
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dasabuvir in hepatitis C (HCV) (2 arms), sponsored by Kaiser Permanente. Primary endpoint: Sustained Virological Response at Week 12. Started Jun 2015; status: completed.
02
Drugs
dasabuvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02461745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02461745.